RNF213 Antikörper (AA 202-350)
-
- Target Alle RNF213 Antikörper anzeigen
- RNF213 (Ring Finger Protein 213 (RNF213))
-
Bindungsspezifität
- AA 202-350
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser RNF213 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human E3 ubiquitin-protein ligase RNF213 protein (202-350AA)
- Isotyp
- IgG
-
anti-Ring Finger Protein 213 (RNF213) (AA 4750-4800) antibody
RNF213 Reaktivität: Human, Maus, Ratte IF (p), IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Ring Finger Protein 213 (RNF213) (AA 2016-2112) antibodyRNF213 Reaktivität: Human ELISA, WB Wirt: Maus Polyclonal unconjugated
anti-Ring Finger Protein 213 (RNF213) (AA 2016-2112) antibodyRNF213 Reaktivität: Human ELISA, WB Wirt: Maus Monoclonal 5C12 unconjugated
anti-Ring Finger Protein 213 (RNF213) (C-Term) antibodyVerified RNF213 Reaktivität: Human ELISA, IHC Wirt: Ziege Polyclonal unconjugated
anti-Ring Finger Protein 213 (RNF213) (N-Term) antibodyRNF213 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Recommended dilution: IHC:1:500-1:1000, IF:1:200-1:500,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- RNF213 (Ring Finger Protein 213 (RNF213))
- Andere Bezeichnung
- RNF213 (RNF213 Produkte)
- Hintergrund
-
Background: E3 ubiquitin-protein ligase involved in angiogenesis (PubMed:21799892, PubMed:26278786, PubMed:26766444, PubMed:26126547). Involved in the non-canonical Wnt signaling pathway in vascular development: acts by mediating ubiquitination and degradation of FLNA and NFATC2 downstream of RSPO3, leading to inhibit the non-canonical Wnt signaling pathway and promoting vessel regression (PubMed:26766444). Also has ATPase activity (PubMed:24658080, PubMed:26126547).
Aliases: ALK lymphoma oligomerization partner on chromosome 17 antibody, C17orf27 antibody, Chromosome 17 open reading frame 27 antibody, E3 ubiquitin-protein ligase RNF213 antibody, FLJ13051 antibody, KIAA1554 antibody, MGC46622 antibody, MGC9929 antibody, MYMY2 antibody, Mysterin antibody, MYSTR antibody, NET57 antibody, RING finger protein 213 antibody, RN213_HUMAN antibody, RNF 213 antibody, RNF213 antibody
- UniProt
- Q63HN8
-
